David Beuther is a Respiratory physician affiliated with National Jewish Health. OpenAlex indexes 55 publications with 2,799 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Jackson St
Denver, CO 802062761
Telephone
303-388-4461Provider last certified this registry record 11 Nov 2020.
Clinical trials
- The Effect of Obesity on Lung Functioning
Sponsor: National Jewish Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year202411 payments$11,510openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
86.9%Corticosteroid45.6%Breo Ellipta36%Symbicort23%Trelegy Ellipta20%Breyna6%Fluticasone Propionate6%Arnuity Ellipta5%Fluticasone Propionate Hfa4%Part D<11 patientsbeta2-Adrenergic Agonist23.3%Albuterol Sulfate Hfa86%Ventolin Hfa14%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
11.2%Corticosteroid8.6%Prednisone100%Part D≥32 patientsH2 blocker2.6%Famotidine100%Part D<11 patientsDermatology
1.8%Interleukin-4 Receptor alpha Antagonist1.8%Dupixent Syringe100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severities
Annals of Allergy Asthma & Immunology
2026 - What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publications
Therapeutic Advances in Respiratory Disease
2025 - Advancing assessment of asthma control with a composite tool
Annals of Allergy Asthma & Immunology
2024 - Assessing meaningful change in the Asthma Impairment and Risk Questionnaire
Annals of Allergy Asthma & Immunology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Donald Leung, MD
National Jewish Health
James Crapo, MD
National Jewish Health
Barry Make, MD
National Jewish Health
Charles Daley, MD
National Jewish Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”